6,651 Shares in Corteva, Inc. $CTVA Bought by Kimelman & Baird LLC

Kimelman & Baird LLC acquired a new stake in shares of Corteva, Inc. (NYSE:CTVAFree Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,651 shares of the company’s stock, valued at approximately $563,000.

A number of other large investors have also added to or reduced their stakes in CTVA. William B. Walkup & Associates Inc. boosted its holdings in shares of Corteva by 2.9% in the 1st quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after buying an additional 126 shares in the last quarter. Wilkerson Advisory Group LLC lifted its position in Corteva by 6.7% during the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock valued at $177,000 after acquiring an additional 133 shares during the last quarter. AdvisorNet Financial Inc lifted its position in Corteva by 2.4% during the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock valued at $477,000 after acquiring an additional 135 shares during the last quarter. First Horizon Corp boosted its stake in Corteva by 9.2% in the first quarter. First Horizon Corp now owns 1,600 shares of the company’s stock valued at $134,000 after acquiring an additional 135 shares in the last quarter. Finally, Aviance Capital Partners LLC boosted its stake in Corteva by 1.3% in the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock valued at $922,000 after acquiring an additional 137 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Citigroup upped their price target on Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. Bank of America boosted their target price on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. UBS Group reduced their target price on Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 18th. Royal Bank Of Canada reiterated an “overweight” rating on shares of Corteva in a research note on Friday. Finally, Mizuho raised their price target on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.

View Our Latest Analysis on Corteva

Corteva Price Performance

Shares of NYSE CTVA opened at $84.00 on Friday. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97. The business’s 50 day moving average price is $82.69 and its 200 day moving average price is $80.54. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The firm has a market cap of $56.04 billion, a P/E ratio of 55.63, a P/E/G ratio of 2.53 and a beta of 0.57.

Corteva (NYSE:CTVAGet Free Report) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. During the same period last year, the firm posted $2.20 EPS. Corteva’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is currently 47.68%.

Corteva Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Read More

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.